John Langenfeld

2.8k total citations
46 papers, 1.9k citations indexed

About

John Langenfeld is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, John Langenfeld has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in John Langenfeld's work include TGF-β signaling in diseases (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Treatments and Mutations (6 papers). John Langenfeld is often cited by papers focused on TGF-β signaling in diseases (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Lung Cancer Treatments and Mutations (6 papers). John Langenfeld collaborates with scholars based in United States, Netherlands and Germany. John Langenfeld's co-authors include Elaine Langenfeld, Ethan Dmitrovsky, Valerie W. Rusch, David S. Klimstra, Peter W. T. Pisters, Fulvio Lonardo, E. S. Venkatraman, David Sekula, Hiroaki Kiyokawa and Jay Boyle and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

John Langenfeld

44 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Langenfeld United States 20 1.1k 740 532 203 174 46 1.9k
Hajime Okita Japan 25 1.2k 1.1× 349 0.5× 550 1.0× 200 1.0× 298 1.7× 124 2.2k
Giovanni Ligresti United States 31 1.2k 1.1× 411 0.6× 639 1.2× 295 1.5× 246 1.4× 59 2.4k
Constantina Petraki Greece 25 577 0.5× 564 0.8× 356 0.7× 330 1.6× 144 0.8× 63 1.7k
Jin Sung Jang United States 24 1.0k 0.9× 516 0.7× 324 0.6× 420 2.1× 122 0.7× 49 1.7k
Jia-Lin Lee South Korea 21 919 0.8× 892 1.2× 503 0.9× 344 1.7× 335 1.9× 50 2.0k
Ying Ma China 20 741 0.7× 620 0.8× 243 0.5× 310 1.5× 133 0.8× 81 1.7k
Laurence Panicot‐Dubois France 27 895 0.8× 816 1.1× 312 0.6× 357 1.8× 297 1.7× 70 2.7k
Eliza Wiercinska Germany 22 1.1k 1.0× 788 1.1× 194 0.4× 316 1.6× 210 1.2× 41 2.1k
Mishie Tanino Japan 25 961 0.9× 533 0.7× 650 1.2× 497 2.4× 201 1.2× 117 2.3k
Hervé Sartelet France 23 807 0.7× 527 0.7× 224 0.4× 377 1.9× 139 0.8× 82 1.7k

Countries citing papers authored by John Langenfeld

Since Specialization
Citations

This map shows the geographic impact of John Langenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Langenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Langenfeld more than expected).

Fields of papers citing papers by John Langenfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Langenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Langenfeld. The network helps show where John Langenfeld may publish in the future.

Co-authorship network of co-authors of John Langenfeld

This figure shows the co-authorship network connecting the top 25 collaborators of John Langenfeld. A scholar is included among the top collaborators of John Langenfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Langenfeld. John Langenfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vora, Mehul, Arindam Mondal, Dongxuan Jia, et al.. (2022). Bone morphogenetic protein signaling regulation of AMPK and PI3K in lung cancer cells and C. elegans. Cell & Bioscience. 12(1). 76–76. 7 indexed citations
2.
Mondal, Arindam, Dongxuan Jia, Vrushank Bhatt, et al.. (2022). Ym155 localizes to the mitochondria leading to mitochondria dysfunction and activation of AMPK that inhibits BMP signaling in lung cancer cells. Scientific Reports. 12(1). 13135–13135. 12 indexed citations
3.
Mondal, Arindam, Jacques Y. Roberge, John Gilleran, et al.. (2022). Bone morphogenetic protein inhibitors and mitochondria targeting agents synergistically induce apoptosis-inducing factor (AIF) caspase-independent cell death in lung cancer cells. Cell Communication and Signaling. 20(1). 99–99. 9 indexed citations
4.
Berim, Lyudmyla, et al.. (2021). Combining radiation therapy and immunotherapy for lung cancers: a narrative review. Shanghai Chest. 5. 10–10. 6 indexed citations
5.
Mondal, Arindam, Mehul Vora, Elaine Langenfeld, et al.. (2021). Bone morphogenetic protein receptor 2 inhibition destabilizes microtubules promoting the activation of lysosomes and cell death of lung cancer cells. Cell Communication and Signaling. 19(1). 97–97. 9 indexed citations
6.
Aisner, Joseph, et al.. (2019). Paravertebral Nerve Block With Liposomal Bupivacaine for Pain Control Following Video-Assisted Thoracoscopic Surgery and Thoracotomy. Journal of Surgical Research. 246. 19–25. 16 indexed citations
7.
Deek, Matthew P., Sinae Kim, Mutlay Sayan, et al.. (2019). Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity. Journal of Gastrointestinal Oncology. 10(3). 513–522. 10 indexed citations
8.
Yegya‐Raman, Nikhil, Joseph Aisner, Sinae Kim, et al.. (2019). Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution. Advances in Radiation Oncology. 4(3). 541–550. 4 indexed citations
9.
Newman, Jenna H., et al.. (2018). Double-Humanized Mouse Model to Study Bone Morphogenetic Protein (BMP) Signaling in Tumor Xenografts. Methods in molecular biology. 1891. 257–262. 1 indexed citations
10.
Langenfeld, Elaine, et al.. (2016). Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death. Molecular Cancer. 15(1). 27–27. 37 indexed citations
11.
Narayanan, Sumana, et al.. (2015). Treatment of Diaphragmatic Hernia Occurring After Transhiatal Esophagectomy. Annals of Surgical Oncology. 22(11). 3681–3686. 22 indexed citations
12.
Eng, Oliver S., Dirk F. Moore, Chunxia Chen, et al.. (2015). Fluid administration and morbidity in transhiatal esophagectomy. Journal of Surgical Research. 200(1). 91–97. 11 indexed citations
13.
Moore, Dirk F., et al.. (2014). Outcome-volume relationships and transhiatal esophagectomy: minimizing failure to rescue. PubMed. 8(1). 9–9. 12 indexed citations
14.
15.
Langenfeld, Elaine, Charles C. Hong, Gandhi Lanke, & John Langenfeld. (2013). Bone Morphogenetic Protein Type I Receptor Antagonists Decrease Growth and Induce Cell Death of Lung Cancer Cell Lines. PLoS ONE. 8(4). e61256–e61256. 43 indexed citations
16.
Aviv, Hana, et al.. (2008). Thymolipoma: clues to pathogenesis revealed by cytogenetics. Annals of Diagnostic Pathology. 13(3). 185–188. 19 indexed citations
17.
Langenfeld, Elaine, et al.. (2005). Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene. 25(5). 685–692. 111 indexed citations
18.
Langenfeld, Elaine, et al.. (2005). Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas. The Annals of Thoracic Surgery. 80(3). 1028–1032. 74 indexed citations
19.
Langenfeld, John. (2003). A new thoracoscopic lung biopsy clamp simplifies excision of pulmonary nodules. The Annals of Thoracic Surgery. 76(1). 307–308.
20.
Boyle, Jay O., John Langenfeld, Fulvio Lonardo, et al.. (1999). Cyclin D1 Proteolysis: a Retinoid Chemoprevention Signal in Normal, Immortalized, and Transformed Human Bronchial Epithelial Cells. JNCI Journal of the National Cancer Institute. 91(4). 373–379. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hajime Okita Breakdown of academic impact, for papers by Giovanni Ligresti Breakdown of academic impact, for papers by Constantina Petraki Breakdown of academic impact, for papers by Jin Sung Jang Breakdown of academic impact, for papers by Jia-Lin Lee Breakdown of academic impact, for papers by Ying Ma Breakdown of academic impact, for papers by Laurence Panicot‐Dubois Breakdown of academic impact, for papers by Eliza Wiercinska Breakdown of academic impact, for papers by Mishie Tanino Breakdown of academic impact, for papers by Hervé Sartelet
Rankless by CCL
2026